Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs KILITCH DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA KILITCH DRUGS CIPLA/
KILITCH DRUGS
 
P/E (TTM) x 26.7 35.3 75.5% View Chart
P/BV x 4.5 2.8 158.1% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 CIPLA   KILITCH DRUGS
EQUITY SHARE DATA
    CIPLA
Mar-24
KILITCH DRUGS
Mar-24
CIPLA/
KILITCH DRUGS
5-Yr Chart
Click to enlarge
High Rs1,519470 323.3%   
Low Rs886141 628.1%   
Sales per share (Unadj.) Rs319.396.0 332.6%  
Earnings per share (Unadj.) Rs51.58.4 609.8%  
Cash flow per share (Unadj.) Rs64.510.5 612.8%  
Dividends per share (Unadj.) Rs13.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs329.8109.4 301.4%  
Shares outstanding (eoy) m807.1516.08 5,019.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.83.2 118.3%   
Avg P/E ratio x23.436.2 64.5%  
P/CF ratio (eoy) x18.629.0 64.2%  
Price / Book Value ratio x3.62.8 130.6%  
Dividend payout %25.30-   
Avg Mkt Cap Rs m970,4574,912 19,757.1%   
No. of employees `000NANA-   
Total wages/salary Rs m43,100100 43,044.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m257,7411,544 16,696.0%  
Other income Rs m7,46645 16,668.2%   
Total revenues Rs m265,2071,589 16,695.3%   
Gross profit Rs m60,962243 25,126.7%  
Depreciation Rs m10,51034 31,373.7%   
Interest Rs m89960 1,489.1%   
Profit before tax Rs m57,019194 29,459.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,46658 26,762.2%   
Profit after tax Rs m41,553136 30,610.0%  
Gross profit margin %23.715.7 150.5%  
Effective tax rate %27.129.9 90.8%   
Net profit margin %16.18.8 183.3%  
BALANCE SHEET DATA
Current assets Rs m193,9251,460 13,283.1%   
Current liabilities Rs m52,458642 8,168.9%   
Net working cap to sales %54.953.0 103.6%  
Current ratio x3.72.3 162.6%  
Inventory Days Days95173 55.3%  
Debtors Days Days71,495 0.5%  
Net fixed assets Rs m126,886915 13,866.6%   
Share capital Rs m1,615161 1,004.0%   
"Free" reserves Rs m264,5841,599 16,551.5%   
Net worth Rs m266,1991,759 15,130.4%   
Long term debt Rs m00-   
Total assets Rs m321,3002,375 13,528.5%  
Interest coverage x64.44.2 1,531.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 123.4%   
Return on assets %13.28.3 160.0%  
Return on equity %15.67.7 202.3%  
Return on capital %21.814.4 150.8%  
Exports to sales %22.20-   
Imports to sales %9.20-   
Exports (fob) Rs m57,150NA-   
Imports (cif) Rs m23,657NA-   
Fx inflow Rs m74,800779 9,596.6%   
Fx outflow Rs m23,657166 14,233.8%   
Net fx Rs m51,143613 8,339.8%   
CASH FLOW
From Operations Rs m41,339-1 -2,831,445.2%  
From Investments Rs m-29,880-95 31,304.7%  
From Financial Activity Rs m-12,00488 -13,630.4%  
Net Cashflow Rs m-490-9 5,541.9%  

Share Holding

Indian Promoters % 10.9 69.2 15.7%  
Foreign collaborators % 20.0 0.0 -  
Indian inst/Mut Fund % 52.9 0.0 -  
FIIs % 28.8 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 69.1 30.8 224.5%  
Shareholders   470,234 9,920 4,740.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Cipla vs KILITCH DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs KILITCH DRUGS Share Price Performance

Period Cipla KILITCH DRUGS S&P BSE HEALTHCARE
1-Day 1.06% 0.79% 0.82%
1-Month -1.99% 1.32% -0.65%
1-Year 16.47% -2.54% 43.04%
3-Year CAGR 18.29% 26.61% 20.19%
5-Year CAGR 25.35% 21.87% 26.14%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the KILITCH DRUGS share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 30.9% stake in the company. In case of KILITCH DRUGS the stake stands at 69.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of KILITCH DRUGS.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 13.0 per share. This amounted to a Dividend Payout ratio of 25.3%.

KILITCH DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Cipla, and the dividend history of KILITCH DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.